CNS Drugs : Impact Factor & More
eISSN: 1179-1934pISSN: 1172-7047
Share this on:
Key Metrics
CiteScore 
9.8
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q1Neurology (clinical)
SNIP
1.87
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on CNS Drugs
CNS Drugs Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1994 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in CNS Drugs ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in CNS Drugs
Comment on "Early High-Risk Opioid Prescribing and Persistent Opioid Use in Australian Workers with Workers' Compensation Claims for Back and Neck Musculoskeletal Disorders or Injuries: A Retrospective Cohort Study".
- 8 Jan 2026
- CNS drugs
Authors' Reply to Abudayeh and Fishchenko: Comment on"Early High-Risk Opioid Prescribing and Persistent Opioid Use in Australian Workers with Workers' Compensation Claims for Back and Neck Musculoskeletal Disorders or Injuries: A Retrospective Cohort Study".
- 8 Jan 2026
- CNS drugs
Psilocybin and Bipolar Depression: Promise and Prudence.
- 4 Jan 2026
- CNS drugs
Pitolisant Improves Depressive Symptoms in CPAP-Treated Patients with Obstructive Sleep Apnea and Severe Residual Sleepiness: First 12-Month Clinical Experience.
- 16 Dec 2025
- CNS drugs
Assessing Cognitive Function over Time in Patients with Refractory Chronic Migraine Who Received Ketamine Infusions: A Prospective, Observational Study.
- 15 Dec 2025
- CNS drugs
The Effect of Psychotropic Medications on Glaucoma Risk and Intraocular Pressure: A Bayesian Meta-Analysis.
- 12 Dec 2025
- CNS drugs
Comment on "Early High-Risk Opioid Prescribing and Persistent Opioid Use in Australian Workers with Workers' Compensation Claims for Back and Neck Musculoskeletal Disorders or Injuries: A Retrospective Cohort Study".
- 8 Jan 2026
- CNS drugs
Authors' Reply to Abudayeh and Fishchenko: Comment on"Early High-Risk Opioid Prescribing and Persistent Opioid Use in Australian Workers with Workers' Compensation Claims for Back and Neck Musculoskeletal Disorders or Injuries: A Retrospective Cohort Study".
- 8 Jan 2026
- CNS drugs
Psilocybin and Bipolar Depression: Promise and Prudence.
- 4 Jan 2026
- CNS drugs
Pitolisant Improves Depressive Symptoms in CPAP-Treated Patients with Obstructive Sleep Apnea and Severe Residual Sleepiness: First 12-Month Clinical Experience.
- 16 Dec 2025
- CNS drugs
Assessing Cognitive Function over Time in Patients with Refractory Chronic Migraine Who Received Ketamine Infusions: A Prospective, Observational Study.
- 15 Dec 2025
- CNS drugs
The Effect of Psychotropic Medications on Glaucoma Risk and Intraocular Pressure: A Bayesian Meta-Analysis.
- 12 Dec 2025
- CNS drugs
FAQs on CNS Drugs
How long has CNS Drugs been actively publishing? 
What is the publishing frequency of CNS Drugs?
How many articles did CNS Drugs publish last year?
What is the eISSN & pISSN for CNS Drugs?
What is Citescore for CNS Drugs?
What is SNIP score for CNS Drugs?
What is the SJR for CNS Drugs?
Who is the publisher of CNS Drugs?
